A non-ablative treatment for benign prostatic hyperplasia (BPH)/lower urinary tract symptoms (LUTS) achieved durable ...
While sales of Talzenna, which Pfizer acquired in a $14 billion deal, have been “negligible” so far, the new results should ...
Many unproven ‘claims’ put your health at risk.
For eight years, Gillian Murphy dreaded cold weather. Winter would leave the 71-year-old's fingers white and freezing - while ...
Vietnam Investment Review on MSN
Zuellig Pharma acquires Cialis rights in three Asian markets from Lilly
SINGAPORE - Media OutReach Newswire - 12 March 2026 - Zuellig Pharma, a leading healthcare solutions company in Asia, today announced that it has acquired all rights, title, and interest in and to ...
SINGAPORE - Media OutReach Newswire - 12 March 2026 - Zuellig Pharma, a leading healthcare solutions company in Asia, today ...
To evaluate the efficacy and safety of a fixed-dose combination (FDC) of dutasteride and tadalafil vs monotherapy in patients with benign prostatic hyperplasia (BPH). This phase III trial enrolled 667 ...
(NewsNation) — A honey product marketed for “energy support” is being recalled after FDA testing revealed the presence of an undeclared ingredient commonly found in erectile dysfunction medication.
(NewsNation) — A honey product marketed for “energy support” is being recalled after FDA testing revealed the presence of an undeclared ingredient commonly found in erectile dysfunction medication.
DUBLIN, Jan. 21, 2026 /PRNewswire/ -- ProVerum Limited, a medical device company focused on innovative, safe and effective solutions for treating benign prostatic hyperplasia (BPH), today announced ...
UCHealth Longs Peak Hospital in Longmont, Colo., is using a robot-assisted procedure that incorporates AI to treat benign prostatic hyperplasia, or BPH, a common condition among older men. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results